Therapeutic Areas

Altea Pharma focuses on therapeutic areas where there are clear medical needs, challenges in drug supply, or opportunities to improve patient treatment through innovative solutions. By combining regulatory expertise, market knowledge, and a patient-centered perspective, we work to increase access to essential medicines and medical devices in the Nordic region.

CNS (Central Nervous System)

Diseases and conditions affecting the central nervous system include ADHD, epilepsy, Parkinson’s disease, Alzheimer’s disease, depression, and other neurological or psychiatric diagnoses. Many of these conditions require long-term treatment where adherence, dosing flexibility, and patient-adapted formulations are crucial for a successful treatment outcome.

Altea Pharma sees great opportunities to contribute with both generic medicines and Value Added Medicines within the CNS field. By introducing alternative dosage forms and improved treatment solutions, we can contribute to increased patient benefit and improved access to vital therapies in the Nordics.

PAIN

Pain is one of the most common reasons for seeking healthcare and includes both acute and chronic conditions. Effective pain management is vital for patients’ quality of life, yet significant challenges remain regarding individualized treatment, adherence, and the balance between efficacy and safety.

In the field of pain management, multiple medications are often used simultaneously to achieve optimal treatment. Despite this, there are still relatively few combination products that simplify treatment for the patient. Combinations of well-established substances can reduce the number of tablets that need to be taken each day, simplify dosing, and contribute to increased adherence.

From a patient perspective, this can mean an easier daily life and better conditions for following prescribed treatment. For healthcare providers, improved adherence can lead to better treatment outcomes, fewer follow-up visits, and a reduced need for treatment adjustments. From a societal perspective, there are also significant benefits through reduced sick leave, lower healthcare costs, and more efficient resource utilization.

Altea Pharma therefore sees great value in developing and introducing both established pain treatments and Value Added Medicines that can contribute to improved patient benefit, simpler treatment, and more sustainable healthcare.

RESPIRATORY

Respiratory diseases, such as asthma, COPD, and respiratory tract infections, affect millions of patients and represent a significant burden on the healthcare system. Treatment places high demands on the correct use of medicines and medical devices, while access to certain treatments can periodically be limited.

By introducing new products and alternative treatment solutions, Altea Pharma aims to help strengthen access to essential therapies in respiratory care. Our ambition is to ensure that patients and healthcare providers have access to effective and user-friendly treatment options.

SLEEP

Sleep disorders are a growing public health issue affecting quality of life, work capacity, and general health. Millions of people suffer from insomnia or other sleep-related issues, while there is a need for treatment options that combine efficacy, safety, and ease of use.

Melatonin plays an important role in regulating the body’s circadian rhythm and is currently used as a treatment for various forms of sleep disorders. The need is particularly high among children, adolescents, and adults with neuropsychiatric diagnoses such as ADHD, where sleep difficulties are common and often affect the daily lives of both the patient and their family.

Despite the growing use of melatonin, the range of patient-adapted dosage forms remains limited. Many patients have difficulty swallowing traditional tablets or require more flexible dosing options. Here, Altea Pharma sees significant opportunities to develop and introduce improved formulations that can increase adherence, simplify treatment, and improve the patient experience.

Through innovative solutions and patient-centered development, Altea Pharma aims to contribute to better sleep treatments and increased access to modern alternatives in the Nordic market.

ANTIBIOTICS

Antibiotics are a fundamental part of modern healthcare and are crucial for treating bacterial infections. At the same time, antibiotic resistance, global supply challenges, and recurring shortages represent some of the greatest challenges for healthcare.

Altea Pharma views antibiotics as a strategically important therapeutic area. By working with established products, alternative formulations, and long-term partnerships, we aim to contribute to a more robust drug supply and ensure access to essential antibiotic treatments in the Nordics. Our focus is on high quality, security of supply, and sustainable solutions that support both patients and healthcare providers.